Article
Molecular genetic testing enabled the diagnosis of otherwise undiagnosable cases of pyruvate kinase deficiency.
Pediatric hematology and oncology - 1 Mar 2022
Chueh Hee Won, Kim Namhee
Abstract excerpt
The gold standard for the diagnosis of pyruvate kinase (PK) deficiency, the most frequent red blood cell enzymopathy, is an enzymatic activity assay. However, this assay is rather unreliable in a clinical setting, often leading to misdiagnosis or missed diagnosis. This report presented the cases of two patients diagnosed with PK deficiency using molecular genetic testing, even though conventional laboratory...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
